Asia Pacific Pulmonary Drug Delivery Market Forecast 2019-2028

Asia Pacific Pulmonary Drug Delivery Market Forecast 2019-2028

The Asia Pacific pulmonary drug delivery market is estimated to grow with a CAGR of 6.50%, over the forecast period of 2019 to 2028. The rising levels of pollutions leading to respiratory conditions, potential growth opportunities within the medical devices division, and supportive government initiatives are projected to drive the region’s market growth.

The Asia Pacific pulmonary drug delivery market growth is evaluated across Japan, Indonesia, China, Vietnam, South Korea, India, Australia & New Zealand, Thailand, and the rest of the Asia Pacific. According to the estimates issued by the World Health Organization (WHO), India fosters at least 15 million patients with asthma. Moreover, the rising levels of pollution in the country have caused an alarming increase in the prevalence of respiratory conditions.
On the other hand, in recent years, India’s healthcare industry has increased by nearly 10%, owing to factors such as growing life expectancy, changing demographics, and surging public awareness. Supportive government initiatives like the Asia Pacific – Asthma Insights and Management (AP-AIM) study, are also accredited to the market’s growth. The initiative strives to understand the availability of a diverse range of affordable and effective drugs, in addition to reliable diagnostic tools across India. Likewise, the country’s ’Make in India’ initiative is a proactive platform for manufacturers to explore the expansion opportunities within the medical devices industry. Thus, these factors are predicted to accelerate the demand for pulmonary drug delivery solutions, and drive the market growth in the region.

Distinguished enterprises operating in the market include, Clement Clarke International, Aerogen, Agilent Technologies Inc, Novartis AG, Teva Pharmaceuticals Industries Limited, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis: Drug Delivery Market
3.2. Development Of Drug Delivery System
3.3. Market Definition
3.4. Key Drivers
3.4.1. Growing Prevalence Of Respiratory Disease
3.4.2. Advancements In Technology
3.4.3. Rising Geriatric Population
3.5. Key Restraints
3.5.1. Stringent Regulation And Patent Expiry
3.5.2. Increasing Drug Recalls And Drug Failures
3.5.3. Side Effects And Risk Associated With The Drugs
4. Key Analytics
4.1. Porter’s Five Force Analysis
4.1.1. Threat Of New Entry
4.1.2. Threat Of Substitution
4.1.3. Buyer’s Power
4.1.4. Supplier’s Power
4.1.5. Competitive Rivalry
4.2. Regulatory Framework
4.3. Impact Of Covid-19 On Pulmonary Drug Delivery Market
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Investment Insights
5. Market By Application
5.1. Asthma
5.2. Chronic Obstructive Pulmonary Disease
5.3. Allergic Rhinitis
5.4. Cystic Fibrosis
5.5. Other Applications
6. Market By Distribution Channel
6.1. Hospital Pharmacies
6.2. Retail Pharmacies
6.3. E-commerce
7. Market By End-user
7.1. Hospitals & Clinics
7.2. Homecare
8. Market By Product
8.1. Metered Dose Inhalers
8.2. Dry Powder Inhalers
8.3. Nebulizer
8.3.1. Pneumatic Nebulizer
8.3.2. Mesh Nebulizer
8.3.3. Ultrasonic Nebulizer
8.4. Accessories
9. Geographical Analysis
9.1. Asia Pacific
9.1.1. China
9.1.2. Japan
9.1.3. India
9.1.4. Australia & New Zealand
9.1.5. South Korea
9.1.6. Thailand
9.1.7. Indonesia
9.1.8. Vietnam
9.1.9. Rest Of Asia Pacific
10. Company Profiles
10.1. 3m Company
10.2. Actelion Pharmaceuticals Ltd
10.3. Aerogen
10.4. Agilent Technologies Inc
10.5. Astrazeneca Plc
10.6. Boehringer Ingelheim Gmbh
10.7. Clement Clarke International
10.8. Gf Health Products Inc
10.9. Glaxosmithkline Plc
10.10. Koninklijke Philips Nv
10.11. Merck & Co Inc
10.12. Novartis Ag
10.13. Teva Pharmaceutical Industries Limited
10.14. Vectura Group Plc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook